DexCom, Inc. v.Abbott Scandinavia Aktiebolag, Newyu,Inc., Abbott Laboratories, Abbott, Abbott B.V., Abbott Oy, Abbott Diagnostics GmbH, Abbott Gesellschaft m.b.H., Abbott S.r.l., Abbott France, Abbott GmbH, Abbott Laboratories A/S, Abbott Diabetes Care Inc., Abbott
Paris (FR) Local Division · UPC-001611
This procedural order concerns an infringement action brought by DexCom, Inc. against fourteen defendants, including multiple Abbott entities and Newyu, Inc., regarding European Patent EP3831282. The dispute centered on the alignment of deadlines for filing the Statement of Defence (SoD) across all defendants, given that service on some defendants was delayed or still in progress. Following a case management meeting where all parties orally agreed on a reasonable extension date, the Judge-Rapporteur ordered that the time limit for filing the SoD be aligned for all defendants, with the starting point set at 15 December 2023 and the SoD expected by 15 March 2024.